Investigating the effect of zinc on pulmonary function in adults with cystic fibrosis

Evalution the effect of zinc supplementation on pulmonary function in adults with cystic fibrosis in Imam Khomeini Hospital in 2023 , Randomize clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20231203060254N1

Enrollment

Registered

2024-02-21

Start date

2024-01-09

Completion date

Unknown

Last updated

2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic fibrosis. Cystic fibrosis

Interventions

Intervention 1: Intervention group: Clinical group 30 mg zinc tablets are given to patients daily. In the second group of patients, they have previously suffered from cystic fibrosis, which was diagno

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: They have a history of suffering from cystic fibrosis, which was confirmed by genetic tests that have been done before

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Spirometry test is performed and its results of fev1, fvc, RV, tlc are statistically compared in 2 groups. Timepoint: Finally after 3 months. Method of measurement: Spirometry.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzad rahmandost

Tehran University of Medical Sciences

fa_rdr@yahoo.com+98 21 6119 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026